AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $141,000 | +6.8% | 10,452 | -6.5% | 0.00% | -25.0% |
Q3 2020 | $132,000 | -19.0% | 11,178 | +1.1% | 0.00% | -20.0% |
Q2 2020 | $163,000 | -35.8% | 11,054 | +5.3% | 0.01% | +25.0% |
Q4 2019 | $254,000 | -33.9% | 10,500 | -47.5% | 0.00% | -50.0% |
Q3 2019 | $384,000 | -35.0% | 20,000 | 0.0% | 0.01% | -50.0% |
Q2 2019 | $591,000 | -64.5% | 20,000 | -42.9% | 0.02% | -61.0% |
Q1 2019 | $1,663,000 | +15.2% | 35,000 | -12.5% | 0.04% | -31.7% |
Q4 2018 | $1,444,000 | -22.1% | 40,000 | +32.8% | 0.06% | +22.4% |
Q3 2018 | $1,854,000 | -21.6% | 30,118 | -13.9% | 0.05% | -14.0% |
Q2 2018 | $2,364,000 | -3.2% | 35,000 | -22.2% | 0.06% | -26.0% |
Q1 2018 | $2,441,000 | -25.7% | 45,000 | -18.2% | 0.08% | -8.3% |
Q4 2017 | $3,286,000 | +35.2% | 55,000 | +10.0% | 0.08% | -6.7% |
Q3 2017 | $2,430,000 | -7.5% | 50,000 | 0.0% | 0.09% | -18.9% |
Q2 2017 | $2,628,000 | -12.2% | 50,000 | -24.2% | 0.11% | -6.7% |
Q1 2017 | $2,993,000 | +19.8% | 66,000 | 0.0% | 0.12% | -1.7% |
Q4 2016 | $2,498,000 | +32.4% | 66,000 | +32.0% | 0.12% | +3.4% |
Q3 2016 | $1,887,000 | +502.9% | 50,000 | +400.0% | 0.12% | +735.7% |
Q1 2015 | $313,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |